FRACTION-RCC: Innovative, high-throughput assessment of nivolumab plus ipilimumab (N+I) for treatment-refractory advanced renal cell carcinoma (aRCC) Meeting Abstract

  


Authors: Loidl, W.; Choueiri, T. K.; Kluger, H.; George, S.; Tykodi, S. S.; Kuzel, T. M.; Perets, R.; Nair, S.; Procopio, G.; Carducci, M.; Castonguay, V.; Folefac, E.; Lee, C. H.; Hotte, S. J.; Miller, W. H.; Saggi, S. S.; Gold, D.; Motzer, R. J.; Escudier, B.
Abstract Title: FRACTION-RCC: Innovative, high-throughput assessment of nivolumab plus ipilimumab (N+I) for treatment-refractory advanced renal cell carcinoma (aRCC)
Meeting Title: 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 4
Meeting Dates: 2020 Oct 9-11
Meeting Location: Virtual
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-10-01
Start Page: 209
Language: English
ACCESSION: WOS:000575955000473
PROVIDER: wos
DOI: 10.1159/000510995
Notes: Meeting Abstract: 205 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer
  2. Chung-Han Lee
    157 Lee
Related MSK Work